A, es nhra Fe deseuestoatg cial uti ng ase HAI Chief Executive Office Circular No. (7) 2020 Date: 17 MAR 2020 To All Medical Device Companies and Healthcare Facilities Subject: Rapid test for Research purposes only & not for diagnosis The National Health Regulatory Authority would like to alert all importers and medical devices companies and Healthcare Facilities that the Repid test for Covid-19 must obtain NHRA approval prior to marketing, importation or usage, Kindly make sure that all your workers are fully aware of this circular. Currently, governmental facilities will be the only approved entity to use this product for research purposes and not for diagnosis. ‘Therefore, NHRA should alert to ensure patient safety and the quality of imported medical devices. Your cooperation is highly appreciated in improving health services in the Kingdom. gon y Gyaullistos Kingdom of Bahrain 2020 Aisal (7) a8) ayant £2020 cade 17 gett Aga a Stina 9 5 5p) CAS pk Qe ool) Kyaaall Glauatgally CE ASH ay pall USI ge 26 pagal yaad juyly batt Goll Gal EY COVID-19 eet pal Ly el ppl Ge lh gh os Cigale Cle jtinally Sigal CIS yo ol Ge: Covid-19 J gyal GSI gh Gana! Sally pal IS Hy! Wily le Sunes eo Sel oa gol SL ga 9 lain] pea ge pe esti gall CN Gi Clad gi ly Le cathy at Can Gal BY al Tbe play dae al oaeall cee LOL le La ym Aull gl) gle Gan Bo nel Rall 5 jg I Sag Uae y ce pilly SAN aja ly dans 9 Le a ASdaadly Raneall Cilasilly oli! Ga tall Si uss ps Aap dlall le ay pa 5 giSall kh) Guill Tel 697397113333 | .0.804:11466, Manama | eMail: infosnbr.bh fax 5997317113359 Kingdom of Bahain Website: worw:hva.bh